Clinical Trial Update: The Medtronic RESOLUTE Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

The Medtronic RESOLUTE clinical trial for coronary artery disease completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Resolute zotarolimus-eluting coronary stent (zotarolimus-eluting coronary stent)

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED